Cargando…
Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
Esophageal squamous cell carcinoma (ESCC) and esophagogastric junction adenocarcinoma (EGJA) are the two main types of gastrointestinal cancers that pose a huge threat to human health. ESCC remains one of the most common malignant diseases around the world. In contrast to the decreasing prevalence o...
Autores principales: | Xu, Yi-Wei, Peng, Yu-Hui, Xu, Li-Yan, Xie, Jian-Jun, Li, En-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747294/ https://www.ncbi.nlm.nih.gov/pubmed/31558856 http://dx.doi.org/10.3748/wjg.v25.i34.5049 |
Ejemplares similares
-
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018) -
Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018) -
Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014) -
Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022) -
Circulating Levels of L1-cell Adhesion Molecule as a Serum Biomarker for Early Detection of Gastric Cancer and Esophagogastric Junction Adenocarcinoma
por: Chu, Ling-Yu, et al.
Publicado: (2020)